186 related articles for article (PubMed ID: 30886222)
1. Muscle contractility in spinobulbar muscular atrophy.
Dahlqvist JR; Oestergaard ST; Poulsen NS; Knak KL; Thomsen C; Vissing J
Sci Rep; 2019 Mar; 9(1):4680. PubMed ID: 30886222
[TBL] [Abstract][Full Text] [Related]
2. Refining the spinobulbar muscular atrophy phenotype by quantitative MRI and clinical assessments.
Dahlqvist JR; Oestergaard ST; Poulsen NS; Thomsen C; Vissing J
Neurology; 2019 Feb; 92(6):e548-e559. PubMed ID: 30610091
[TBL] [Abstract][Full Text] [Related]
3. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.
Breza M; Koutsis G
J Neurol; 2019 Mar; 266(3):565-573. PubMed ID: 30006721
[TBL] [Abstract][Full Text] [Related]
4. Disease progression and outcome measures in spinobulbar muscular atrophy.
Dahlqvist JR; Fornander F; de Stricker Borch J; Oestergaard ST; Poulsen NS; Vissing J
Ann Neurol; 2018 Nov; 84(5):754-765. PubMed ID: 30255951
[TBL] [Abstract][Full Text] [Related]
5. Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients.
Grunseich C; Zukosky K; Kats IR; Ghosh L; Harmison GG; Bott LC; Rinaldi C; Chen KL; Chen G; Boehm M; Fischbeck KH
Neurobiol Dis; 2014 Oct; 70():12-20. PubMed ID: 24925468
[TBL] [Abstract][Full Text] [Related]
6. Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice.
Gray AL; Annan L; Dick JRT; La Spada AR; Hanna MG; Greensmith L; Malik B
Dis Model Mech; 2020 May; 13(5):. PubMed ID: 32152060
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy.
Katsuno M; Banno H; Suzuki K; Adachi H; Tanaka F; Sobue G
Arch Neurol; 2012 Apr; 69(4):436-40. PubMed ID: 22158719
[TBL] [Abstract][Full Text] [Related]
8. In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.
Pennuto M; Basso M
J Mol Neurosci; 2016 Mar; 58(3):365-73. PubMed ID: 26614347
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the Androgen Receptor by Antiandrogens in Spinobulbar Muscle Atrophy.
Baniahmad A
J Mol Neurosci; 2016 Mar; 58(3):343-7. PubMed ID: 26563449
[TBL] [Abstract][Full Text] [Related]
10. Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy.
Mano T; Katsuno M; Banno H; Suzuki K; Suga N; Hashizume A; Araki A; Watanabe H; Tanaka S; Yamamoto M; Sobue G
Neurology; 2014 Jan; 82(3):255-62. PubMed ID: 24353334
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Genotype-Phenotype Correlation of Korean Patients with Spinal and Bulbar Muscular Atrophy.
Song JS; Kim KA; Min JH; Ki CS; Kim JW; Sung DH; Kim BJ
Yonsei Med J; 2015 Jul; 56(4):993-7. PubMed ID: 26069122
[TBL] [Abstract][Full Text] [Related]
12. [Study of androgen receptor expression and neuronal vulnerability in X-linked spinal and bulbar muscular atrophy].
Matsuura T
Hokkaido Igaku Zasshi; 1996 Nov; 71(6):785-99. PubMed ID: 8996845
[TBL] [Abstract][Full Text] [Related]
13. Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA).
Hashizume A; Fischbeck KH; Pennuto M; Fratta P; Katsuno M
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1085-1091. PubMed ID: 32934110
[TBL] [Abstract][Full Text] [Related]
14. Exercise Therapy in Spinobulbar Muscular Atrophy and Other Neuromuscular Disorders.
Dahlqvist JR; Vissing J
J Mol Neurosci; 2016 Mar; 58(3):388-93. PubMed ID: 26585990
[TBL] [Abstract][Full Text] [Related]
15. Correlation between the CAG repeat size and electrophysiological findings in patients with spinal and bulbar muscular atrophy.
Kim H; Lim YM; Lee EJ; Oh YJ; Kim KK
Muscle Nerve; 2018 Apr; 57(4):683-686. PubMed ID: 28972672
[TBL] [Abstract][Full Text] [Related]
16. Antiandrogen flutamide protects male mice from androgen-dependent toxicity in three models of spinal bulbar muscular atrophy.
Renier KJ; Troxell-Smith SM; Johansen JA; Katsuno M; Adachi H; Sobue G; Chua JP; Sun Kim H; Lieberman AP; Breedlove SM; Jordan CL
Endocrinology; 2014 Jul; 155(7):2624-34. PubMed ID: 24742193
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of spinal and bulbar muscular atrophy from amyotrophic lateral sclerosis using sensory nerve action potentials.
Hama T; Hirayama M; Hara T; Nakamura T; Atsuta N; Banno H; Suzuki K; Katsuno M; Tanaka F; Sobue G
Muscle Nerve; 2012 Feb; 45(2):169-74. PubMed ID: 22246870
[TBL] [Abstract][Full Text] [Related]
18. Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy.
Johansen JA; Yu Z; Mo K; Monks DA; Lieberman AP; Breedlove SM; Jordan CL
Neurobiol Dis; 2009 Apr; 34(1):113-20. PubMed ID: 19211034
[TBL] [Abstract][Full Text] [Related]
19. Pre-clinical symptoms of SBMA may not be androgen-dependent: implications from two SBMA mouse models.
Xu Y; Halievski K; Katsuno M; Adachi H; Sobue G; Breedlove SM; Jordan CL
Hum Mol Genet; 2018 Jul; 27(14):2425-2442. PubMed ID: 29897452
[TBL] [Abstract][Full Text] [Related]
20. [Two brothers with very late onset of muscle weakness in X-linked recessive spinal and bulbar muscular atrophy].
Hemmi S; Inoue K; Kutoku Y; Rikimaru M; Murakami T; Sunada Y
Rinsho Shinkeigaku; 2009 Jan; 49(1):22-6. PubMed ID: 19227892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
